China's policies on stem cell research: An opportunity for international collaborations

Nature Reviews Molecular Cell Biology

Volumn 10, Issue 4, 2009, Pages 286-

  Jin, Xi ^a   Zheng, Lin ^a   Zheng, Ruo Heng ^b   Li, You Ming ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b HANGZHOU RED CROSS HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CLONING; CELL NUCLEUS TRANSPLANTATION; CHINA; EMBRYONIC STEM CELL; FUNDING; HEALTH CARE POLICY; HUMAN; HUMAN CELL; IN VITRO STUDY; LETTER; MEDICAL RESEARCH; MEDICOLEGAL ASPECT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; SOMATIC CELL;

CHINA; EMBRYO RESEARCH; HUMANS; INTERNATIONAL COOPERATION; STEM CELLS;

EID: 62849111897     PISSN: 14710072     EISSN: 14710080     Source Type: Journal    
DOI: 10.1038/nrm2528-c1     Document Type: Letter

References (4)

1. Hynes, R. O. US policies on human embryonic stem cells. Nature Rev. Mol. Cell Biol. 9, 993-997 (2008).
2. Lovell-Badge, R. The regulation of human embryo and stem-cell research in the United Kingdom. Nature Rev. Mol. Cell Biol. 9, 998-1003 (2008).
3. Ethics Committee of the Chinese National Human Genome Center at Shanghai. Ethical guidelines for human embryonic stem cell research. Kennedy Inst. Ethics J. 14, 47-54 (2004).
4. Salter, B., Cooper, M. & Dickins, A. China and the global stem cell bioeconomy: an emerging political strategy? Regen. Med. 1, 671-683 (2006).